Alejandro Beceiro Selected Research

LN 1-255

10/2019	Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii.
11/2017	Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro Beceiro Research Topics

Disease

13	Infections 01/2022 - 09/2004
4	Pneumonia (Pneumonitis) 01/2021 - 05/2015
3	Pseudomonas Infections 01/2022 - 11/2020
2	Cross Infection (Nosocomial Infection) 01/2021 - 09/2012
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Tuberculosis (Tuberculoses) 02/2016
1	Dehydration (Water Stress) 07/2015
1	Cystic Fibrosis (Mucoviscidosis) 05/2010
1	Body Weight (Weight, Body) 10/2009
1	Urinary Tract Infections (Urinary Tract Infection) 05/2007

Drug/Important Bio-Agent (IBA)

6	Carbapenems (Carbapenem Antibiotics)IBA 02/2021 - 06/2010
3	tazobactam drug combination ceftolozaneIBA 01/2022 - 11/2020
2	ceftazidime drug combination avibactamIBA 01/2022 - 01/2021
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 11/2014
2	LactamsIBA 12/2020 - 09/2012
2	Imipenem FDA Link 10/2019 - 09/2012
2	LN 1-255IBA 10/2019 - 11/2017
2	Pharmaceutical PreparationsIBA 05/2015 - 10/2009
1	acinetobactinIBA 01/2021
1	SiderophoresIBA 01/2021
1	CephalosporinaseIBA 01/2021
1	IronIBA 01/2021
1	carbapenemaseIBA 12/2020
1	Peptide Nucleic AcidsIBA 01/2020
1	Histidine (L-Histidine)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Phosphates (Orthophosphate)IBA 02/2016
1	Adenosine Triphosphate (ATP)IBA 02/2016
1	Schiff Bases (Schiff Base)IBA 07/2015
1	EnzymesIBA 07/2015
1	CyclohexaneIBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	VaccinesIBA 05/2015
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 09/2012
1	Ceftazidime (Fortum)FDA LinkGeneric 09/2012
1	ceftolozaneIBA 09/2012
1	AmpC beta-lactamasesIBA 05/2010
1	PorinsIBA 05/2010
1	Disinfectants (Biocides)IBA 09/2007
1	Anti-Infective Agents (Microbicides)IBA 09/2007
1	beta-Lactamases (beta-Lactamase)IBA 05/2007
1	Cephalosporins (Cephalosporin Antibiotics)IBA 09/2004

Therapy/Procedure

2	Therapeutics 01/2020 - 10/2019